PORTOLA PHARMACEUTICALS

Codice
PTLA
Risorse esterne
Opinione della community
Prezzo Variazione Volume
66.315 +2.13 €
(+3.32%)
100886
P/E Obiettivo ad 1anno
0 60.21 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 4
Sell : 2

elena pecchio alessandro

Commenti


Notizie

Insider Trading Activity Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) – insider Sold 10000 shares of Stock - Market Exclusive

John T. Curnutte , insider of Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) reportedly Sold 10,000 shares of the company's stock at an average price of 65 for a total transaction amount of $650,000.00 SEC Form. Insider Trading History For Portola ... Leggi

Portola Pharmaceuticals: Expect Additional Upside From Here - Benzinga

Even after Portola Pharmaceuticals Inc (NASDAQ: PTLA) shares soared nearly 50 percent following news of betrixaban receiving FDA approval (reported on Benzinga Pro), Oppenheimer analyst Jay Olson sees further upside. Olson maintains an Outperform ... Leggi

Portola Pharma stock skyrockets after FDA approves anticoagulant for high-risk patients - MarketWatch

Portola Pharmaceuticals Inc. PTLA, +1.97% shares skyrocketed 46% in extremely heavy Friday afternoon trade after the Food and Drug Administration approved its anticoagulant drug intended for high-risk patients. The drug, Bevyxxa, is the first and only ... Leggi

Rail-Splitter Capital Management Stake in Portola Pharmaceuticals Ptla (PTLA) Has Decreased as Shares Rose; Nvr ... - FlintDaily.com

Rail-Splitter Capital Management Llc who had been investing in Portola Pharmaceuticals Inc. Ptla for a number of months, seems to be less bullish one the $3.80 billion market cap company. The stock increased 0.08% or $0.05 during the last trading ... Leggi

A Look at 2 Trending Stocks: Soligenix, Inc. (SNGX), Portola ... - Post Analyst

Soligenix, Inc. (NASDAQ:SNGX) recently saw its volume around 0.95 million shares and on average it trades 0.69 million shares a day. The opening price of ...altro » Leggi

Traders Secrets on Uni-Pixel, Inc. (UNXL), Portola Pharmaceuticals, Inc. (PTLA) - StockNewsJournal

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA), stock is trading $42.74 above the 52-week high. The 1 year EPS growth rate is -9.30% . Its share price has risen 2.54% in three months and is up 7.02% for the last five trades. The average analysts gave this ...altro » Leggi

Jul 19, 2017 - Harvey Capital Management Inc Buys BlackRock Inc ... - GuruFocus.com

Harvey Capital Management Inc Buys BlackRock Inc, Raytheon Co, Broadcom, Sells Time Warner Inc, Oracle Corp, Portola Pharmaceuticals Inc, Stocks: AVGO ...altro » Leggi

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) Trading Down – Insiders and Institutional Investors Selling - Highlight Press

There has been some selling insider activity on Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) recently. EVP Mardi Dier let go of 23,350 shares at an average price of $60.00 on Tue the 11th. The EVP now owns $0 of the stock as recorded in a recent Form 4 ... Leggi

Hot Stocks Among Investors: Wal-Mart Stores, Inc. (WMT), Portola Pharmaceuticals, Inc. (PTLA) - Post Analyst

Turning to Portola Pharmaceuticals, Inc. (NASDAQ:PTLA), its shares were trading at $63.24 a gain of $0.82, on the trading floor. The stock, after opening at $62.86, touched a high of $64.15 before paring much of its gains. So far, analysts are sticking ...altro » Leggi

Portola Pharmaceuticals Inc (PTLA) CEO William Lis Sold $14.9 million of Shares - Nasdaq

Portola Pharmaceuticals Inc is a biopharmaceutical company. It develops & commercializes novel therapeutics in the areas of thrombosis, other hematologic disorders & inflammation for patients who currently have limited or no approved treatment options. Leggi